Cargando…

Outcomes among oropharyngeal and oral cavity cancer patients treated with postoperative volumetric modulated arctherapy

BACKGROUND: Presently, there are few published reports on postoperative radiation therapy for oropharyngeal and oral cavity cancers treated with IMRT/VMAT technique. This study aimed to assess the oncological outcomes of this population treated with postoperative VMAT in our institution, with a focu...

Descripción completa

Detalles Bibliográficos
Autores principales: Mione, Cécile, Casile, Mélanie, Moreau, Juliette, Miroir, Jessica, Molnar, Ioana, Chautard, Emmanuel, Bernadach, Maureen, Kossai, Myriam, Saroul, Nicolas, Martin, F., Pham-Dang, Nathalie, Lapeyre, Michel, Biau, Julian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10644788/
https://www.ncbi.nlm.nih.gov/pubmed/38023128
http://dx.doi.org/10.3389/fonc.2023.1272856
_version_ 1785134624150650880
author Mione, Cécile
Casile, Mélanie
Moreau, Juliette
Miroir, Jessica
Molnar, Ioana
Chautard, Emmanuel
Bernadach, Maureen
Kossai, Myriam
Saroul, Nicolas
Martin, F.
Pham-Dang, Nathalie
Lapeyre, Michel
Biau, Julian
author_facet Mione, Cécile
Casile, Mélanie
Moreau, Juliette
Miroir, Jessica
Molnar, Ioana
Chautard, Emmanuel
Bernadach, Maureen
Kossai, Myriam
Saroul, Nicolas
Martin, F.
Pham-Dang, Nathalie
Lapeyre, Michel
Biau, Julian
author_sort Mione, Cécile
collection PubMed
description BACKGROUND: Presently, there are few published reports on postoperative radiation therapy for oropharyngeal and oral cavity cancers treated with IMRT/VMAT technique. This study aimed to assess the oncological outcomes of this population treated with postoperative VMAT in our institution, with a focus on loco-regional patterns of failure. MATERIAL AND METHODS: Between 2011 and 2019, 167 patients were included (40% of oropharyngeal cancers, and 60% of oral cavity cancers). The median age was 60 years. There was 64.2% of stage IV cancers. All patients had both T and N surgery. 34% had a R1 margin, 42% had perineural invasion. 72% had a positive neck dissection and 42% extranodal extension (ENE). All patients were treated with VMAT with simultaneous integrated boost with three dose levels: 66Gy in case of R1 margin and/or ENE, 59.4-60Gy on the tumor bed, and 54Gy on the prophylactic areas. Concomittant cisplatin was administrated concomitantly when feasible in case of R1 and/or ENE. RESULTS: The 1- and 2-year loco-regional control rates were 88.6% and 85.6% respectively. Higher tumor stage (T3/T4), the presence of PNI, and time from surgery >45 days were significant predictive factors of worse loco-regional control in multivariate analysis (p=0.02, p=0.04, and p=0.02). There were 17 local recurrences: 11 (64%) were considered as infield, 4 (24%) as marginal, and 2 (12%) as outfield. There were 9 regional recurrences only, 8 (89%) were considered as infield, and 1 (11%) as outfield. The 1- and 2-year disease-free survival (DFS) rates were 78.9% and 71.8% respectively. The 1- and 2-year overall survival (OS) rates were 88.6% and 80% respectively. Higher tumor stage (T3/T4) and the presence of ENE were the two prognostic factors significantly associated with worse DFS and OS in multivariate analysis. CONCLUSION: Our outcomes for postoperative VMAT for oral cavity and oropharyngeal cancers are encouraging, with high rates of loco-regional control. However, the management of ENE still seems challenging.
format Online
Article
Text
id pubmed-10644788
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-106447882023-01-01 Outcomes among oropharyngeal and oral cavity cancer patients treated with postoperative volumetric modulated arctherapy Mione, Cécile Casile, Mélanie Moreau, Juliette Miroir, Jessica Molnar, Ioana Chautard, Emmanuel Bernadach, Maureen Kossai, Myriam Saroul, Nicolas Martin, F. Pham-Dang, Nathalie Lapeyre, Michel Biau, Julian Front Oncol Oncology BACKGROUND: Presently, there are few published reports on postoperative radiation therapy for oropharyngeal and oral cavity cancers treated with IMRT/VMAT technique. This study aimed to assess the oncological outcomes of this population treated with postoperative VMAT in our institution, with a focus on loco-regional patterns of failure. MATERIAL AND METHODS: Between 2011 and 2019, 167 patients were included (40% of oropharyngeal cancers, and 60% of oral cavity cancers). The median age was 60 years. There was 64.2% of stage IV cancers. All patients had both T and N surgery. 34% had a R1 margin, 42% had perineural invasion. 72% had a positive neck dissection and 42% extranodal extension (ENE). All patients were treated with VMAT with simultaneous integrated boost with three dose levels: 66Gy in case of R1 margin and/or ENE, 59.4-60Gy on the tumor bed, and 54Gy on the prophylactic areas. Concomittant cisplatin was administrated concomitantly when feasible in case of R1 and/or ENE. RESULTS: The 1- and 2-year loco-regional control rates were 88.6% and 85.6% respectively. Higher tumor stage (T3/T4), the presence of PNI, and time from surgery >45 days were significant predictive factors of worse loco-regional control in multivariate analysis (p=0.02, p=0.04, and p=0.02). There were 17 local recurrences: 11 (64%) were considered as infield, 4 (24%) as marginal, and 2 (12%) as outfield. There were 9 regional recurrences only, 8 (89%) were considered as infield, and 1 (11%) as outfield. The 1- and 2-year disease-free survival (DFS) rates were 78.9% and 71.8% respectively. The 1- and 2-year overall survival (OS) rates were 88.6% and 80% respectively. Higher tumor stage (T3/T4) and the presence of ENE were the two prognostic factors significantly associated with worse DFS and OS in multivariate analysis. CONCLUSION: Our outcomes for postoperative VMAT for oral cavity and oropharyngeal cancers are encouraging, with high rates of loco-regional control. However, the management of ENE still seems challenging. Frontiers Media S.A. 2023-10-31 /pmc/articles/PMC10644788/ /pubmed/38023128 http://dx.doi.org/10.3389/fonc.2023.1272856 Text en Copyright © 2023 Mione, Casile, Moreau, Miroir, Molnar, Chautard, Bernadach, Kossai, Saroul, Martin, Pham-Dang, Lapeyre and Biau https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Mione, Cécile
Casile, Mélanie
Moreau, Juliette
Miroir, Jessica
Molnar, Ioana
Chautard, Emmanuel
Bernadach, Maureen
Kossai, Myriam
Saroul, Nicolas
Martin, F.
Pham-Dang, Nathalie
Lapeyre, Michel
Biau, Julian
Outcomes among oropharyngeal and oral cavity cancer patients treated with postoperative volumetric modulated arctherapy
title Outcomes among oropharyngeal and oral cavity cancer patients treated with postoperative volumetric modulated arctherapy
title_full Outcomes among oropharyngeal and oral cavity cancer patients treated with postoperative volumetric modulated arctherapy
title_fullStr Outcomes among oropharyngeal and oral cavity cancer patients treated with postoperative volumetric modulated arctherapy
title_full_unstemmed Outcomes among oropharyngeal and oral cavity cancer patients treated with postoperative volumetric modulated arctherapy
title_short Outcomes among oropharyngeal and oral cavity cancer patients treated with postoperative volumetric modulated arctherapy
title_sort outcomes among oropharyngeal and oral cavity cancer patients treated with postoperative volumetric modulated arctherapy
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10644788/
https://www.ncbi.nlm.nih.gov/pubmed/38023128
http://dx.doi.org/10.3389/fonc.2023.1272856
work_keys_str_mv AT mionececile outcomesamongoropharyngealandoralcavitycancerpatientstreatedwithpostoperativevolumetricmodulatedarctherapy
AT casilemelanie outcomesamongoropharyngealandoralcavitycancerpatientstreatedwithpostoperativevolumetricmodulatedarctherapy
AT moreaujuliette outcomesamongoropharyngealandoralcavitycancerpatientstreatedwithpostoperativevolumetricmodulatedarctherapy
AT miroirjessica outcomesamongoropharyngealandoralcavitycancerpatientstreatedwithpostoperativevolumetricmodulatedarctherapy
AT molnarioana outcomesamongoropharyngealandoralcavitycancerpatientstreatedwithpostoperativevolumetricmodulatedarctherapy
AT chautardemmanuel outcomesamongoropharyngealandoralcavitycancerpatientstreatedwithpostoperativevolumetricmodulatedarctherapy
AT bernadachmaureen outcomesamongoropharyngealandoralcavitycancerpatientstreatedwithpostoperativevolumetricmodulatedarctherapy
AT kossaimyriam outcomesamongoropharyngealandoralcavitycancerpatientstreatedwithpostoperativevolumetricmodulatedarctherapy
AT saroulnicolas outcomesamongoropharyngealandoralcavitycancerpatientstreatedwithpostoperativevolumetricmodulatedarctherapy
AT martinf outcomesamongoropharyngealandoralcavitycancerpatientstreatedwithpostoperativevolumetricmodulatedarctherapy
AT phamdangnathalie outcomesamongoropharyngealandoralcavitycancerpatientstreatedwithpostoperativevolumetricmodulatedarctherapy
AT lapeyremichel outcomesamongoropharyngealandoralcavitycancerpatientstreatedwithpostoperativevolumetricmodulatedarctherapy
AT biaujulian outcomesamongoropharyngealandoralcavitycancerpatientstreatedwithpostoperativevolumetricmodulatedarctherapy